CymaBay gets FDA orphan drug status for MBX-8025 to treat hypertriglyceridemia
MBX-8025 is a potent and selective peroxisome proliferator-activated receptor delta (PPARd) agonist currently being evaluated by the company in high unmet need and orphan diseases. Recently, MBX-8025 also
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.